Correlation Between PhaseBio Pharmaceuticals and Mosaic Immunoengineerin

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PhaseBio Pharmaceuticals and Mosaic Immunoengineerin at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PhaseBio Pharmaceuticals and Mosaic Immunoengineerin into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PhaseBio Pharmaceuticals and Mosaic Immunoengineering, you can compare the effects of market volatilities on PhaseBio Pharmaceuticals and Mosaic Immunoengineerin and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PhaseBio Pharmaceuticals with a short position of Mosaic Immunoengineerin. Check out your portfolio center. Please also check ongoing floating volatility patterns of PhaseBio Pharmaceuticals and Mosaic Immunoengineerin.

Diversification Opportunities for PhaseBio Pharmaceuticals and Mosaic Immunoengineerin

-0.03
  Correlation Coefficient

Good diversification

The 3 months correlation between PhaseBio and Mosaic is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding PhaseBio Pharmaceuticals and Mosaic Immunoengineering in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mosaic Immunoengineering and PhaseBio Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PhaseBio Pharmaceuticals are associated (or correlated) with Mosaic Immunoengineerin. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mosaic Immunoengineering has no effect on the direction of PhaseBio Pharmaceuticals i.e., PhaseBio Pharmaceuticals and Mosaic Immunoengineerin go up and down completely randomly.

Pair Corralation between PhaseBio Pharmaceuticals and Mosaic Immunoengineerin

If you would invest  82.00  in Mosaic Immunoengineering on August 31, 2024 and sell it today you would earn a total of  17.00  from holding Mosaic Immunoengineering or generate 20.73% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy4.55%
ValuesDaily Returns

PhaseBio Pharmaceuticals  vs.  Mosaic Immunoengineering

 Performance 
       Timeline  
PhaseBio Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PhaseBio Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, PhaseBio Pharmaceuticals is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
Mosaic Immunoengineering 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Mosaic Immunoengineering are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting primary indicators, Mosaic Immunoengineerin showed solid returns over the last few months and may actually be approaching a breakup point.

PhaseBio Pharmaceuticals and Mosaic Immunoengineerin Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with PhaseBio Pharmaceuticals and Mosaic Immunoengineerin

The main advantage of trading using opposite PhaseBio Pharmaceuticals and Mosaic Immunoengineerin positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PhaseBio Pharmaceuticals position performs unexpectedly, Mosaic Immunoengineerin can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mosaic Immunoengineerin will offset losses from the drop in Mosaic Immunoengineerin's long position.
The idea behind PhaseBio Pharmaceuticals and Mosaic Immunoengineering pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
CEOs Directory
Screen CEOs from public companies around the world
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes